Apollo
logo
  1. Home
  2. salt
  3. Metformin+pioglitazone+voglibose

Metformin+pioglitazone+voglibose

About Metformin+pioglitazone+voglibose

Metformin+pioglitazone+voglibose is a prescription oral medication used to manage type 2 diabetes mellitus in adults. Its primary medical purpose is to control high blood sugar levels when diet, exercise, and single-drug therapies are not enough. By keeping blood sugar within a healthy range, it helps prevent serious long-term complications of diabetes.

For this medicine to work effectively, you must take it consistently and exactly as prescribed by your doctor. It is typically taken with meals, specifically with the first bite of your main meals. Incorporating a balanced diet, regular physical activity, and weight management will significantly improve your overall treatment results.

While taking Metformin+pioglitazone+voglibose, you may experience some common side effects like an upset stomach, mild diarrhea, or a metallic taste in your mouth. However, if you notice any unusual or serious symptoms, such as severe abdominal pain, persistent nausea, or yellowing of your eyes or skin, you should consult your doctor immediately.

Before starting this treatment, tell your doctor if you have a history of heart failure, kidney disease, liver disease, bladder cancer or blood in your urine that has not been investigated, or if you have osteoporosis or are at increased risk of bone fractures. Do not take this medicine if you have severe kidney failure, active liver disease, severe heart failure, diabetic ketoacidosis, or active bladder cancer.

This medicine can interact with alcohol, which increases the risk of a rare but serious condition called lactic acidosis, so it is best to limit or avoid alcohol completely. If you are pregnant, planning to become pregnant, breastfeeding, or are over the age of 65, consult your healthcare provider to discuss whether this medication is appropriate for you.

Uses of Metformin+pioglitazone+voglibose

Metformin+pioglitazone+voglibose is used in the treatment of Type II diabetes mellitus. The detailed uses of Metformin+pioglitazone+voglibose are as follows: • Type 2 diabetes mellitus management: Metformin+pioglitazone+voglibose used to control high blood sugar levels in adults when diet, exercise, and treatment with one or two medications do not provide sufficient glycemic control. • Improves insulin sensitivity: Metformin+pioglitazone+voglibose enhances the body’s ability to respond to insulin, helping tissues absorb and utilize glucose more effectively. • Reduces liver glucose production: Metformin+pioglitazone+voglibose lowers the amount of sugar produced by the liver, contributing to reduced fasting blood sugar levels. • Delays carbohydrate absorption: Metformin+pioglitazone+voglibose slows down the digestion and absorption of carbohydrates in the intestine, which helps prevent blood sugar spikes after meals. • Comprehensive glucose control: Metformin+pioglitazone+voglibose targets multiple pathways involved in blood sugar regulation to provide steady, all-day glycemic balance.

Medicinal Benefits

  • Helps lower and control high blood sugar through the combined action of three medicines that work in different ways.
  • Reduces blood sugar spikes after meals, helping maintain more stable glucose levels throughout the day.
  • Improves overall blood sugar control, reducing the daily effects of high blood sugar such as tiredness and fatigue.
  • Helps achieve and maintain your HbA1c target, improving long-term diabetes management.
  • Reduces the risk of diabetes-related complications when used regularly along with a healthy diet and exercise.
  • Helps protect the kidneys from damage caused by long-term high blood sugar.
  • Lowers the risk of nerve damage (diabetic neuropathy), which can cause numbness, tingling, or pain in the hands and feet.
  • Helps protect the eyes by reducing the risk of diabetes-related vision problems.
  • Supports heart and blood vessel health, lowering the risk of cardiovascular complications associated with uncontrolled diabetes.
  • Promotes better long-term health and quality of life by maintaining blood sugar within the target range recommended by your doctor.

Directions for Use

  • Take Metformin+pioglitazone+voglibose with or without food or as advised by a doctor.
  • Follow your doctor's instructions on the dosage and timing of this medication, to ensure the safety.
  • Swallow the medicine as a whole with a glass of water.
  • Do not crush, break, or chew it.

Storage

Store in a cool and dry place away from sunlight

Side Effects of Metformin+pioglitazone+voglibose

Common Side Effects (Usually mild):

  • Upset stomach or mild abdominal pain
  • Mild diarrhea or loose stools
  • Gas, bloating, or flatulence
  • A metallic taste in the mouth
  • Mild weight gain


Serious Side Effects (Call a doctor right away):

  • Signs of lactic acidosis (extreme tiredness, unusual muscle pain, trouble breathing, cold feeling, or unexplained slow heartbeat)
  • Signs of liver damage (yellowing of the skin or eyes, dark urine, or severe nausea and vomiting)
  • Signs of heart problems or fluid retention (sudden swelling in your ankles, feet, or legs, rapid weight gain, or unusual shortness of breath)
  • Signs of low blood sugar (sudden sweating, shaking, dizziness, rapid heartbeat, or confusion)
  • Severe allergic reactions (rash, itching, hives, or swelling of the face, lips, or throat)

Drug Warnings

  • Always carry a fast-acting source of sugar, such as glucose tablets, fruit juice, or hard candy, in case you experience signs of low blood sugar.
  • Make sure to attend all scheduled appointments for blood tests, as your doctor will need to monitor your kidney and liver function regularly.
  • Check your feet and lower legs every day for signs of swelling or sudden fluid retention, and report any changes to your doctor immediately.
  • Inform any healthcare provider you visit—including dentists and surgeons—that you are taking Metformin+pioglitazone+voglibose, as it may need to be temporarily paused before certain medical procedures.
  • Tell your doctor immediately if you notice blood in your urine, painful urination, or a frequent urge to urinate, as these symptoms should be evaluated before continuing treatment.
  • Long-term use of the pioglitazone component may slightly increase the risk of bone fractures, particularly in postmenopausal women. Follow your doctor's advice regarding calcium, vitamin D, exercise, and bone health.
  • If you are scheduled for a CT scan or X-ray that uses iodinated contrast dye, remind your healthcare provider that you are taking metformin, as it may need to be temporarily paused.

Drug Interactions

  • Other Diabetes Medications: Taking this medicine alongside insulin or sulfonylureas may increase your risk of low blood sugar.
  • Water Pills (Diuretics): Some diuretics may raise blood sugar levels, making Metformin+pioglitazone+voglibose less effective.
  • Blood Pressure Medications: Certain beta-blockers may mask the warning signs of low blood sugar, such as a rapid heart rate.

Drug-Drug Interactions Checker List:

  • PIOGLITAZONE
  • CLOPIDOGREL
  • GATIFLOXACIN
  • LEFLUNOMIDE
  • Safety Advice

    • Safety Warning

      Alcohol

      unsafe

      You are recommended to avoid consumption of alcohol with Metformin+pioglitazone+voglibose as it may increase the risk of lactic acidosis (accumulation of lactic acid in the body).

    • Safety Warning

      Pregnancy

      caution

      The safety of Metformin+pioglitazone+voglibose in pregnancy has not been established. Do not use Metformin+pioglitazone+voglibose unless prescribed by the doctor.

    • Safety Warning

      Breast Feeding

      caution

      The safety of Metformin+pioglitazone+voglibose in nursing has not been established.; your doctor will decide whether breastfeeding mothers can take Metformin+pioglitazone+voglibose or not.

    • Safety Warning

      Driving

      caution

      Your driving ability may be affected if your blood sugar levels are too high or too low. Do not drive or operate machinery if you also experience dizziness or drowsiness.

    • Safety Warning

      Liver

      caution

      Inform your doctor before receiving Metformin+pioglitazone+voglibose if you have had a liver impairment/disorder history. Your doctor will prescribe only if the benefits outweigh the risks.

    • Safety Warning

      Kidney

      caution

      Inform your doctor before receiving Metformin+pioglitazone+voglibose if you have had a kidney impairment/disorder history. Your doctor will prescribe only if the benefits outweigh the risks.

    • Safety Warning

      Children

      unsafe

      Metformin+pioglitazone+voglibose is not recommended for children as the safety and effectiveness were not established.

    Habit Forming

    No

    Diet & Lifestyle Advise

    • Monitor Carbohydrate Intake: Work with a dietitian to establish a consistent daily carbohydrate budget, as this medicine directly affects how your body processes dietary sugars.
    • Incorporate Regular Exercise: Engage in moderate physical activity, like brisk walking, for at least 150 minutes per week. Exercise naturally improves your body's sensitivity to insulin.
    • Keep a Blood Sugar Log: Test and record your blood sugar levels regularly as advised by your doctor to track how well your treatment is working.
    • Stay Well Hydrated: Drink plenty of water throughout the day to support your kidney function, which is essential for safely clearing this medicine from your system.
    • Inspect Your Feet Daily: Check your feet daily for cuts, sores, red spots, or swelling, as proper foot care is vital for anyone managing diabetes.
    • Know Your HbA1c Goal: Ask your doctor about your target HbA1c level. For many adults with type 2 diabetes, the usual goal is below 7%, although your target may differ depending on your age, other medical conditions, and overall health.

    Special Advise

    • Regular blood tests are recommended while taking Metformin+pioglitazone+voglibose to monitor blood sugar levels.

    Patients Concern

    Disease/Condition Glossary

    Type 2 diabetes: It is a chronic (long-lasting) condition that keeps the body away from properly utilizing insulin. Hence, people affected with type 2 diabetes either do not produce enough insulin, or there is resistance to the action of insulin. Middle-aged or older are most likely to suffer from type 2 diabetes, so it is also known as adult-onset diabetes. Symptoms of type 2 diabetes include frequent urination at night, increased thirst, slow wound healing, increased hunger, fatigue, and blurred vision. In some cases, weight gain may occur, while in rare cases, weight loss may be observed. The complication of type 2 diabetes also includes nerve problems, kidney problems, damaged retina of eyes or blindness, loss of limbs, sexual dysfunction, and increased chance of heart attack or stroke.

    FAQs

    Metformin+pioglitazone+voglibose belongs to a class of medicines called anti-diabetic drugs used in the treatment of type 2 diabetes, especially in patients whose blood sugar levels are not controlled by diet and exercise alone.

    Metformin+pioglitazone+voglibose contains Voglibose, Metformin and Pioglitazone. Voglibose works by inhibiting the intestinal enzymes responsible for breaking complex sugars into simple sugars like glucose. This process prevents the rise of blood glucose levels. Metformin works by reducing the sugar production by cells in the liver and delays sugar absorption from the intestines. Also, it increases the sensitivity of muscle cells to insulin which enables these cells to remove sugar more effectively from the blood. Pioglitazone works by increasing the sensitivity of liver, muscle and fat cells to insulin and enables cells to remove glucose from blood more effectively. Thereby, Metformin+pioglitazone+voglibose helps to control blood sugar levels.

    Metformin+pioglitazone+voglibose may increase the risk of low blood sugar levels, especially with alcohol intake, when you exercise more than usual, delay or miss snacks or meals. However, if you experience any signs of low blood pressure, such as dizziness, nausea, light-headedness, dehydration or fainting, please consult a doctor.

    You are not recommended to stop taking Metformin+pioglitazone+voglibose on your own as discontinuing Metformin+pioglitazone+voglibose suddenly may cause recurring symptoms or worsen the condition. However, if you experience any difficulty while taking Metformin+pioglitazone+voglibose, please consult your doctor so that alternative medicine may be prescribed.

    Yes, some components of Metformin+pioglitazone+voglibose, particularly pioglitazone, can cause mild weight gain due to fluid retention or improved glucose storage. Talk to your doctor or pharmacist if you notice rapid or unexpected weight gain, especially in your ankles or legs.

    No, it is highly recommended to take Metformin+pioglitazone+voglibose with your meals, ideally with the first bite of food. Taking it with food reduces stomach upset and allows the medication to effectively delay carbohydrate digestion. Talk to your doctor or pharmacist for specific timing advice.

    One of the active components in this medicine is cleared by the kidneys. Your doctor will perform routine blood tests to check your kidney function before and during your treatment to ensure the medicine remains safe for you. Talk to your doctor or pharmacist if you have concerns.

    No, drinking alcohol while taking Metformin+pioglitazone+voglibose is not recommended. Alcohol increases the risk of dangerous low blood sugar episodes and raises the risk of lactic acidosis, a rare but life-threatening condition. Talk to your doctor or pharmacist about your lifestyle habits.

    You may notice improvements in your post-meal blood sugar levels within a few days, but it can take several weeks of consistent use to see the full benefits on your daily glucose levels and long-term HbA1c. Talk to your doctor or pharmacist if your blood sugar remains consistently high.

    Tell your doctor and the radiology team that you are taking Metformin+pioglitazone+voglibose. The metformin component may need to be temporarily stopped before or after the procedure until your kidney function has been checked. Follow your doctor's instructions on when to restart the medicine.

    The pioglitazone component has been associated with a small increased risk of bladder cancer in some studies, particularly with long-term use. This medicine should not be used in people with active bladder cancer. Tell your doctor immediately if you notice blood in your urine, pain while passing urine, or frequent urination, so these symptoms can be evaluated promptly.

    Apollo 247 Floating Button